Free Trial
→ Your book is inside (From Profits Run) (Ad)tc pixel
NASDAQ:GCTK

GlucoTrack Q2 2024 Earnings Report

GlucoTrack logo
$0.67 +0.00 (+0.67%)
Closing price 04:00 PM Eastern
Extended Trading
$0.67 +0.00 (+0.54%)
As of 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

GlucoTrack EPS Results

Actual EPS
-$984.00
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

GlucoTrack Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

GlucoTrack Announcement Details

Quarter
Q2 2024
Date
8/13/2024
Time
N/A
Conference Call Date
Tuesday, August 13, 2024
Conference Call Time
8:00AM ET

Conference Call Resources

Powered by Quartr

Earnings Documents

GlucoTrack's Q2 2024 Quarterly reportQuarterly report
(10-Q)

GlucoTrack Earnings Headlines

GlucoTrack (NASDAQ:GCTK) Upgraded to "Sell" at Wall Street Zen
May 30, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30808482
Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association’s 2026 Scientific Sessions
May 26, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/glucotrack-to-highlight-implantable-continuous-blood-glucose-monitoring-technology-at-the-american-diabetes-association-s-2026-scientific-sessions-1036193706
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history. CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500.tc pixel
June 3 at 1:00 AM  |  Brownstone Research (Ad)
Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association's 2026 Scientific Sessions
May 26, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/26/3301032/0/en/glucotrack-to-highlight-implantable-continuous-blood-glucose-monitoring-technology-at-the-american-diabetes-association-s-2026-scientific-sessions.html
GlucoTrack, Inc.: Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
May 15, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-05/68505758-glucotrack-inc-glucotrack-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights-399.htm
Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
May 14, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/14/3295471/0/en/glucotrack-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights.html
See More GlucoTrack Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GlucoTrack? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GlucoTrack and other key companies, straight to your email.

About GlucoTrack

GlucoTrack (NASDAQ:GCTK), a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

View GlucoTrack Profile
Earnings Tools